- Conditions
- Pain, Postoperative
- Interventions
- Gabapentin, Acetaminophen, Celecoxib, Ketorolac, Paracervical block with ropivacaine, Local anesthetic injection with ropivacaine at abdominal laparoscopic port sites, Hydromorphone, Oxycodone
- Drug · Procedure
- Lead sponsor
- State University of New York at Buffalo
- Other
- Eligibility
- 25 Years to 90 Years · Female only
- Enrollment
- 68 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Williamsville, New York
Source: ClinicalTrials.gov public record
Updated Jul 31, 2023 · Synced May 22, 2026, 12:21 AM EDT